跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
Approvals
/
Health Canada
/
VISTASEAL
Authorized
STANDARD
VISTASEAL
INSTITUTO GRIFOLS SA
🇨🇦 Health Canada
Approval Date
Jul 4, 2025
Approval ID
cc3a738643757b37
Company
INSTITUTO GRIFOLS SA
Type
Standard
Approval Details
Approval Id
cc3a738643757b37
Drug Approval Canada Name
VISTASEAL
Product Name
VISTASEAL
Status
Marketed
Status Date
2023-04-10
Original Market Date
2023-04-10
Din
02514222
Drug Class
Human
Dosage Form
Solution
Route Of Administration
Topical
Schedule
Schedule D
Ahfs
20:28.16
Atc Original
B02BC30 COMBINATIONS
Atc Name
b 02 bc 30
Aig Number
0252708002
Company Name
INSTITUTO GRIFOLS SA
Company Address
Poligono Levante. C/ Can Guasch, 2, Parets Del Valles, Barcelona, Spain, 08150
Company Detail Path
/organization/instituto-grifols-sa
Company Information
Pharmaceutical Company Name
INSTITUTO GRIFOLS SA
Country Name
Spain
Province Name
Barcelona
City Name
parets del valles,barcelona,country_es
Address
CALLE CAN GUASCH (PG LEVANTE) 2
Active Ingredients
FIBRINOGEN (HUMAN)
80 MG / 1 ML
THROMBIN (HUMAN)
500 UNIT / 1 ML
Authorized
Quick Info
Agency
Health Canada
Country
🇨🇦
Approval Date
Jul 4, 2025
Approval ID
cc3a738643757b37
Type
Standard
Back to Health Canada Approvals
VISTASEAL - Health Canada Drug Approval Details